nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Feeling abnormal—Etoposide—hematologic cancer	0.000303	0.000303	CcSEcCtD
Gadoteridol—Oedema—Betamethasone—hematologic cancer	0.000303	0.000303	CcSEcCtD
Gadoteridol—Oedema—Dexamethasone—hematologic cancer	0.000303	0.000303	CcSEcCtD
Gadoteridol—Anaphylactic shock—Betamethasone—hematologic cancer	0.000303	0.000303	CcSEcCtD
Gadoteridol—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000303	0.000303	CcSEcCtD
Gadoteridol—Diarrhoea—Irinotecan—hematologic cancer	0.000303	0.000303	CcSEcCtD
Gadoteridol—Diarrhoea—Mitoxantrone—hematologic cancer	0.000303	0.000303	CcSEcCtD
Gadoteridol—Vomiting—Carmustine—hematologic cancer	0.000303	0.000303	CcSEcCtD
Gadoteridol—Dizziness—Vincristine—hematologic cancer	0.000301	0.000301	CcSEcCtD
Gadoteridol—Rash—Carmustine—hematologic cancer	0.0003	0.0003	CcSEcCtD
Gadoteridol—Ill-defined disorder—Prednisone—hematologic cancer	0.0003	0.0003	CcSEcCtD
Gadoteridol—Dermatitis—Carmustine—hematologic cancer	0.0003	0.0003	CcSEcCtD
Gadoteridol—Vomiting—Alitretinoin—hematologic cancer	0.0003	0.0003	CcSEcCtD
Gadoteridol—Paraesthesia—Triamcinolone—hematologic cancer	0.0003	0.0003	CcSEcCtD
Gadoteridol—Feeling abnormal—Prednisolone—hematologic cancer	0.000299	0.000299	CcSEcCtD
Gadoteridol—Headache—Carmustine—hematologic cancer	0.000298	0.000298	CcSEcCtD
Gadoteridol—Shock—Betamethasone—hematologic cancer	0.000298	0.000298	CcSEcCtD
Gadoteridol—Shock—Dexamethasone—hematologic cancer	0.000298	0.000298	CcSEcCtD
Gadoteridol—Dyspnoea—Triamcinolone—hematologic cancer	0.000298	0.000298	CcSEcCtD
Gadoteridol—Rash—Alitretinoin—hematologic cancer	0.000297	0.000297	CcSEcCtD
Gadoteridol—Dermatitis—Alitretinoin—hematologic cancer	0.000297	0.000297	CcSEcCtD
Gadoteridol—Vomiting—Ifosfamide—hematologic cancer	0.000296	0.000296	CcSEcCtD
Gadoteridol—Hypersensitivity—Cisplatin—hematologic cancer	0.000296	0.000296	CcSEcCtD
Gadoteridol—Bradycardia—Epirubicin—hematologic cancer	0.000296	0.000296	CcSEcCtD
Gadoteridol—Headache—Alitretinoin—hematologic cancer	0.000295	0.000295	CcSEcCtD
Gadoteridol—Diarrhoea—Gemcitabine—hematologic cancer	0.000295	0.000295	CcSEcCtD
Gadoteridol—Nausea—Thalidomide—hematologic cancer	0.000294	0.000294	CcSEcCtD
Gadoteridol—Rash—Ifosfamide—hematologic cancer	0.000294	0.000294	CcSEcCtD
Gadoteridol—Dermatitis—Ifosfamide—hematologic cancer	0.000294	0.000294	CcSEcCtD
Gadoteridol—Hyperhidrosis—Betamethasone—hematologic cancer	0.000293	0.000293	CcSEcCtD
Gadoteridol—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000293	0.000293	CcSEcCtD
Gadoteridol—Dizziness—Irinotecan—hematologic cancer	0.000293	0.000293	CcSEcCtD
Gadoteridol—Urticaria—Etoposide—hematologic cancer	0.000292	0.000292	CcSEcCtD
Gadoteridol—Malaise—Prednisone—hematologic cancer	0.000292	0.000292	CcSEcCtD
Gadoteridol—Rhinitis—Epirubicin—hematologic cancer	0.000291	0.000291	CcSEcCtD
Gadoteridol—Abdominal pain—Etoposide—hematologic cancer	0.000291	0.000291	CcSEcCtD
Gadoteridol—Body temperature increased—Etoposide—hematologic cancer	0.000291	0.000291	CcSEcCtD
Gadoteridol—Syncope—Prednisone—hematologic cancer	0.00029	0.00029	CcSEcCtD
Gadoteridol—Tinnitus—Methotrexate—hematologic cancer	0.000289	0.000289	CcSEcCtD
Gadoteridol—Vomiting—Vincristine—hematologic cancer	0.000289	0.000289	CcSEcCtD
Gadoteridol—Urticaria—Prednisolone—hematologic cancer	0.000288	0.000288	CcSEcCtD
Gadoteridol—Sweating—Doxorubicin—hematologic cancer	0.000287	0.000287	CcSEcCtD
Gadoteridol—Rash—Vincristine—hematologic cancer	0.000287	0.000287	CcSEcCtD
Gadoteridol—Dermatitis—Vincristine—hematologic cancer	0.000286	0.000286	CcSEcCtD
Gadoteridol—Pain—Triamcinolone—hematologic cancer	0.000286	0.000286	CcSEcCtD
Gadoteridol—Headache—Vincristine—hematologic cancer	0.000285	0.000285	CcSEcCtD
Gadoteridol—Loss of consciousness—Prednisone—hematologic cancer	0.000284	0.000284	CcSEcCtD
Gadoteridol—Hypotension—Dexamethasone—hematologic cancer	0.000283	0.000283	CcSEcCtD
Gadoteridol—Hypotension—Betamethasone—hematologic cancer	0.000283	0.000283	CcSEcCtD
Gadoteridol—Nausea—Carmustine—hematologic cancer	0.000283	0.000283	CcSEcCtD
Gadoteridol—Vomiting—Mitoxantrone—hematologic cancer	0.000281	0.000281	CcSEcCtD
Gadoteridol—Vomiting—Irinotecan—hematologic cancer	0.000281	0.000281	CcSEcCtD
Gadoteridol—Nausea—Alitretinoin—hematologic cancer	0.00028	0.00028	CcSEcCtD
Gadoteridol—Convulsion—Prednisone—hematologic cancer	0.00028	0.00028	CcSEcCtD
Gadoteridol—Hypertension—Prednisone—hematologic cancer	0.000279	0.000279	CcSEcCtD
Gadoteridol—Rash—Irinotecan—hematologic cancer	0.000279	0.000279	CcSEcCtD
Gadoteridol—Rash—Mitoxantrone—hematologic cancer	0.000279	0.000279	CcSEcCtD
Gadoteridol—Dermatitis—Irinotecan—hematologic cancer	0.000279	0.000279	CcSEcCtD
Gadoteridol—Dermatitis—Mitoxantrone—hematologic cancer	0.000279	0.000279	CcSEcCtD
Gadoteridol—Headache—Mitoxantrone—hematologic cancer	0.000277	0.000277	CcSEcCtD
Gadoteridol—Headache—Irinotecan—hematologic cancer	0.000277	0.000277	CcSEcCtD
Gadoteridol—Nausea—Ifosfamide—hematologic cancer	0.000277	0.000277	CcSEcCtD
Gadoteridol—Feeling abnormal—Triamcinolone—hematologic cancer	0.000275	0.000275	CcSEcCtD
Gadoteridol—Diarrhoea—Cisplatin—hematologic cancer	0.000275	0.000275	CcSEcCtD
Gadoteridol—Anxiety—Prednisone—hematologic cancer	0.000274	0.000274	CcSEcCtD
Gadoteridol—Vomiting—Gemcitabine—hematologic cancer	0.000274	0.000274	CcSEcCtD
Gadoteridol—Bradycardia—Doxorubicin—hematologic cancer	0.000274	0.000274	CcSEcCtD
Gadoteridol—Paraesthesia—Dexamethasone—hematologic cancer	0.000272	0.000272	CcSEcCtD
Gadoteridol—Paraesthesia—Betamethasone—hematologic cancer	0.000272	0.000272	CcSEcCtD
Gadoteridol—Discomfort—Prednisone—hematologic cancer	0.000272	0.000272	CcSEcCtD
Gadoteridol—Rash—Gemcitabine—hematologic cancer	0.000272	0.000272	CcSEcCtD
Gadoteridol—Dermatitis—Gemcitabine—hematologic cancer	0.000272	0.000272	CcSEcCtD
Gadoteridol—Hypersensitivity—Etoposide—hematologic cancer	0.000271	0.000271	CcSEcCtD
Gadoteridol—Tinnitus—Epirubicin—hematologic cancer	0.000271	0.000271	CcSEcCtD
Gadoteridol—Erythema—Methotrexate—hematologic cancer	0.00027	0.00027	CcSEcCtD
Gadoteridol—Headache—Gemcitabine—hematologic cancer	0.00027	0.00027	CcSEcCtD
Gadoteridol—Nausea—Vincristine—hematologic cancer	0.00027	0.00027	CcSEcCtD
Gadoteridol—Flushing—Epirubicin—hematologic cancer	0.00027	0.00027	CcSEcCtD
Gadoteridol—Rhinitis—Doxorubicin—hematologic cancer	0.000269	0.000269	CcSEcCtD
Gadoteridol—Hypersensitivity—Prednisolone—hematologic cancer	0.000268	0.000268	CcSEcCtD
Gadoteridol—Urticaria—Triamcinolone—hematologic cancer	0.000265	0.000265	CcSEcCtD
Gadoteridol—Dysgeusia—Methotrexate—hematologic cancer	0.000265	0.000265	CcSEcCtD
Gadoteridol—Body temperature increased—Triamcinolone—hematologic cancer	0.000264	0.000264	CcSEcCtD
Gadoteridol—Anaphylactic shock—Prednisone—hematologic cancer	0.000264	0.000264	CcSEcCtD
Gadoteridol—Oedema—Prednisone—hematologic cancer	0.000264	0.000264	CcSEcCtD
Gadoteridol—Nausea—Irinotecan—hematologic cancer	0.000263	0.000263	CcSEcCtD
Gadoteridol—Nausea—Mitoxantrone—hematologic cancer	0.000263	0.000263	CcSEcCtD
Gadoteridol—Pruritus—Etoposide—hematologic cancer	0.00026	0.00026	CcSEcCtD
Gadoteridol—Shock—Prednisone—hematologic cancer	0.00026	0.00026	CcSEcCtD
Gadoteridol—Pain—Betamethasone—hematologic cancer	0.000259	0.000259	CcSEcCtD
Gadoteridol—Pain—Dexamethasone—hematologic cancer	0.000259	0.000259	CcSEcCtD
Gadoteridol—Nausea—Gemcitabine—hematologic cancer	0.000256	0.000256	CcSEcCtD
Gadoteridol—Vomiting—Cisplatin—hematologic cancer	0.000256	0.000256	CcSEcCtD
Gadoteridol—Hyperhidrosis—Prednisone—hematologic cancer	0.000255	0.000255	CcSEcCtD
Gadoteridol—Rash—Cisplatin—hematologic cancer	0.000253	0.000253	CcSEcCtD
Gadoteridol—Dermatitis—Cisplatin—hematologic cancer	0.000253	0.000253	CcSEcCtD
Gadoteridol—Erythema—Epirubicin—hematologic cancer	0.000253	0.000253	CcSEcCtD
Gadoteridol—Diarrhoea—Etoposide—hematologic cancer	0.000252	0.000252	CcSEcCtD
Gadoteridol—Ill-defined disorder—Methotrexate—hematologic cancer	0.000251	0.000251	CcSEcCtD
Gadoteridol—Tinnitus—Doxorubicin—hematologic cancer	0.000251	0.000251	CcSEcCtD
Gadoteridol—Feeling abnormal—Dexamethasone—hematologic cancer	0.00025	0.00025	CcSEcCtD
Gadoteridol—Feeling abnormal—Betamethasone—hematologic cancer	0.00025	0.00025	CcSEcCtD
Gadoteridol—Flushing—Doxorubicin—hematologic cancer	0.000249	0.000249	CcSEcCtD
Gadoteridol—Dysgeusia—Epirubicin—hematologic cancer	0.000248	0.000248	CcSEcCtD
Gadoteridol—Hypersensitivity—Triamcinolone—hematologic cancer	0.000246	0.000246	CcSEcCtD
Gadoteridol—Malaise—Methotrexate—hematologic cancer	0.000244	0.000244	CcSEcCtD
Gadoteridol—Dizziness—Etoposide—hematologic cancer	0.000243	0.000243	CcSEcCtD
Gadoteridol—Urticaria—Dexamethasone—hematologic cancer	0.000241	0.000241	CcSEcCtD
Gadoteridol—Urticaria—Betamethasone—hematologic cancer	0.000241	0.000241	CcSEcCtD
Gadoteridol—Dizziness—Prednisolone—hematologic cancer	0.00024	0.00024	CcSEcCtD
Gadoteridol—Abdominal pain—Betamethasone—hematologic cancer	0.00024	0.00024	CcSEcCtD
Gadoteridol—Abdominal pain—Dexamethasone—hematologic cancer	0.00024	0.00024	CcSEcCtD
Gadoteridol—Body temperature increased—Dexamethasone—hematologic cancer	0.00024	0.00024	CcSEcCtD
Gadoteridol—Body temperature increased—Betamethasone—hematologic cancer	0.00024	0.00024	CcSEcCtD
Gadoteridol—Nausea—Cisplatin—hematologic cancer	0.000239	0.000239	CcSEcCtD
Gadoteridol—Paraesthesia—Prednisone—hematologic cancer	0.000237	0.000237	CcSEcCtD
Gadoteridol—Pruritus—Triamcinolone—hematologic cancer	0.000236	0.000236	CcSEcCtD
Gadoteridol—Cough—Methotrexate—hematologic cancer	0.000236	0.000236	CcSEcCtD
Gadoteridol—Ill-defined disorder—Epirubicin—hematologic cancer	0.000235	0.000235	CcSEcCtD
Gadoteridol—Convulsion—Methotrexate—hematologic cancer	0.000234	0.000234	CcSEcCtD
Gadoteridol—Vomiting—Etoposide—hematologic cancer	0.000234	0.000234	CcSEcCtD
Gadoteridol—Erythema—Doxorubicin—hematologic cancer	0.000234	0.000234	CcSEcCtD
Gadoteridol—Rash—Etoposide—hematologic cancer	0.000232	0.000232	CcSEcCtD
Gadoteridol—Dermatitis—Etoposide—hematologic cancer	0.000232	0.000232	CcSEcCtD
Gadoteridol—Headache—Etoposide—hematologic cancer	0.000231	0.000231	CcSEcCtD
Gadoteridol—Chest pain—Methotrexate—hematologic cancer	0.00023	0.00023	CcSEcCtD
Gadoteridol—Dysgeusia—Doxorubicin—hematologic cancer	0.000229	0.000229	CcSEcCtD
Gadoteridol—Rash—Prednisolone—hematologic cancer	0.000229	0.000229	CcSEcCtD
Gadoteridol—Dermatitis—Prednisolone—hematologic cancer	0.000229	0.000229	CcSEcCtD
Gadoteridol—Malaise—Epirubicin—hematologic cancer	0.000228	0.000228	CcSEcCtD
Gadoteridol—Headache—Prednisolone—hematologic cancer	0.000228	0.000228	CcSEcCtD
Gadoteridol—Discomfort—Methotrexate—hematologic cancer	0.000227	0.000227	CcSEcCtD
Gadoteridol—Syncope—Epirubicin—hematologic cancer	0.000227	0.000227	CcSEcCtD
Gadoteridol—Loss of consciousness—Epirubicin—hematologic cancer	0.000222	0.000222	CcSEcCtD
Gadoteridol—Dizziness—Triamcinolone—hematologic cancer	0.000221	0.000221	CcSEcCtD
Gadoteridol—Cough—Epirubicin—hematologic cancer	0.000221	0.000221	CcSEcCtD
Gadoteridol—Anaphylactic shock—Methotrexate—hematologic cancer	0.000221	0.000221	CcSEcCtD
Gadoteridol—Convulsion—Epirubicin—hematologic cancer	0.000219	0.000219	CcSEcCtD
Gadoteridol—Nausea—Etoposide—hematologic cancer	0.000219	0.000219	CcSEcCtD
Gadoteridol—Hypertension—Epirubicin—hematologic cancer	0.000218	0.000218	CcSEcCtD
Gadoteridol—Feeling abnormal—Prednisone—hematologic cancer	0.000217	0.000217	CcSEcCtD
Gadoteridol—Ill-defined disorder—Doxorubicin—hematologic cancer	0.000217	0.000217	CcSEcCtD
Gadoteridol—Nausea—Prednisolone—hematologic cancer	0.000216	0.000216	CcSEcCtD
Gadoteridol—Chest pain—Epirubicin—hematologic cancer	0.000215	0.000215	CcSEcCtD
Gadoteridol—Anxiety—Epirubicin—hematologic cancer	0.000215	0.000215	CcSEcCtD
Gadoteridol—Pruritus—Betamethasone—hematologic cancer	0.000214	0.000214	CcSEcCtD
Gadoteridol—Pruritus—Dexamethasone—hematologic cancer	0.000214	0.000214	CcSEcCtD
Gadoteridol—Hyperhidrosis—Methotrexate—hematologic cancer	0.000213	0.000213	CcSEcCtD
Gadoteridol—Discomfort—Epirubicin—hematologic cancer	0.000213	0.000213	CcSEcCtD
Gadoteridol—Vomiting—Triamcinolone—hematologic cancer	0.000212	0.000212	CcSEcCtD
Gadoteridol—Malaise—Doxorubicin—hematologic cancer	0.000211	0.000211	CcSEcCtD
Gadoteridol—Rash—Triamcinolone—hematologic cancer	0.000211	0.000211	CcSEcCtD
Gadoteridol—Dry mouth—Epirubicin—hematologic cancer	0.000211	0.000211	CcSEcCtD
Gadoteridol—Dermatitis—Triamcinolone—hematologic cancer	0.00021	0.00021	CcSEcCtD
Gadoteridol—Syncope—Doxorubicin—hematologic cancer	0.00021	0.00021	CcSEcCtD
Gadoteridol—Urticaria—Prednisone—hematologic cancer	0.00021	0.00021	CcSEcCtD
Gadoteridol—Headache—Triamcinolone—hematologic cancer	0.000209	0.000209	CcSEcCtD
Gadoteridol—Abdominal pain—Prednisone—hematologic cancer	0.000209	0.000209	CcSEcCtD
Gadoteridol—Body temperature increased—Prednisone—hematologic cancer	0.000209	0.000209	CcSEcCtD
Gadoteridol—Diarrhoea—Betamethasone—hematologic cancer	0.000207	0.000207	CcSEcCtD
Gadoteridol—Diarrhoea—Dexamethasone—hematologic cancer	0.000207	0.000207	CcSEcCtD
Gadoteridol—Anaphylactic shock—Epirubicin—hematologic cancer	0.000206	0.000206	CcSEcCtD
Gadoteridol—Oedema—Epirubicin—hematologic cancer	0.000206	0.000206	CcSEcCtD
Gadoteridol—Hypotension—Methotrexate—hematologic cancer	0.000206	0.000206	CcSEcCtD
Gadoteridol—Loss of consciousness—Doxorubicin—hematologic cancer	0.000206	0.000206	CcSEcCtD
Gadoteridol—Cough—Doxorubicin—hematologic cancer	0.000204	0.000204	CcSEcCtD
Gadoteridol—Shock—Epirubicin—hematologic cancer	0.000203	0.000203	CcSEcCtD
Gadoteridol—Convulsion—Doxorubicin—hematologic cancer	0.000203	0.000203	CcSEcCtD
Gadoteridol—Hypertension—Doxorubicin—hematologic cancer	0.000202	0.000202	CcSEcCtD
Gadoteridol—Dizziness—Dexamethasone—hematologic cancer	0.0002	0.0002	CcSEcCtD
Gadoteridol—Dizziness—Betamethasone—hematologic cancer	0.0002	0.0002	CcSEcCtD
Gadoteridol—Hyperhidrosis—Epirubicin—hematologic cancer	0.0002	0.0002	CcSEcCtD
Gadoteridol—Chest pain—Doxorubicin—hematologic cancer	0.000199	0.000199	CcSEcCtD
Gadoteridol—Anxiety—Doxorubicin—hematologic cancer	0.000199	0.000199	CcSEcCtD
Gadoteridol—Nausea—Triamcinolone—hematologic cancer	0.000198	0.000198	CcSEcCtD
Gadoteridol—Paraesthesia—Methotrexate—hematologic cancer	0.000198	0.000198	CcSEcCtD
Gadoteridol—Discomfort—Doxorubicin—hematologic cancer	0.000197	0.000197	CcSEcCtD
Gadoteridol—Dyspnoea—Methotrexate—hematologic cancer	0.000197	0.000197	CcSEcCtD
Gadoteridol—Dry mouth—Doxorubicin—hematologic cancer	0.000195	0.000195	CcSEcCtD
Gadoteridol—Hypersensitivity—Prednisone—hematologic cancer	0.000194	0.000194	CcSEcCtD
Gadoteridol—Hypotension—Epirubicin—hematologic cancer	0.000193	0.000193	CcSEcCtD
Gadoteridol—Vomiting—Dexamethasone—hematologic cancer	0.000193	0.000193	CcSEcCtD
Gadoteridol—Vomiting—Betamethasone—hematologic cancer	0.000193	0.000193	CcSEcCtD
Gadoteridol—Rash—Dexamethasone—hematologic cancer	0.000191	0.000191	CcSEcCtD
Gadoteridol—Rash—Betamethasone—hematologic cancer	0.000191	0.000191	CcSEcCtD
Gadoteridol—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000191	0.000191	CcSEcCtD
Gadoteridol—Oedema—Doxorubicin—hematologic cancer	0.000191	0.000191	CcSEcCtD
Gadoteridol—Dermatitis—Dexamethasone—hematologic cancer	0.000191	0.000191	CcSEcCtD
Gadoteridol—Dermatitis—Betamethasone—hematologic cancer	0.000191	0.000191	CcSEcCtD
Gadoteridol—Headache—Betamethasone—hematologic cancer	0.00019	0.00019	CcSEcCtD
Gadoteridol—Headache—Dexamethasone—hematologic cancer	0.00019	0.00019	CcSEcCtD
Gadoteridol—Pain—Methotrexate—hematologic cancer	0.000189	0.000189	CcSEcCtD
Gadoteridol—Shock—Doxorubicin—hematologic cancer	0.000188	0.000188	CcSEcCtD
Gadoteridol—Pruritus—Prednisone—hematologic cancer	0.000187	0.000187	CcSEcCtD
Gadoteridol—Paraesthesia—Epirubicin—hematologic cancer	0.000185	0.000185	CcSEcCtD
Gadoteridol—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000185	0.000185	CcSEcCtD
Gadoteridol—Dyspnoea—Epirubicin—hematologic cancer	0.000184	0.000184	CcSEcCtD
Gadoteridol—Feeling abnormal—Methotrexate—hematologic cancer	0.000182	0.000182	CcSEcCtD
Gadoteridol—Diarrhoea—Prednisone—hematologic cancer	0.000181	0.000181	CcSEcCtD
Gadoteridol—Nausea—Dexamethasone—hematologic cancer	0.00018	0.00018	CcSEcCtD
Gadoteridol—Nausea—Betamethasone—hematologic cancer	0.00018	0.00018	CcSEcCtD
Gadoteridol—Hypotension—Doxorubicin—hematologic cancer	0.000178	0.000178	CcSEcCtD
Gadoteridol—Pain—Epirubicin—hematologic cancer	0.000176	0.000176	CcSEcCtD
Gadoteridol—Urticaria—Methotrexate—hematologic cancer	0.000175	0.000175	CcSEcCtD
Gadoteridol—Dizziness—Prednisone—hematologic cancer	0.000175	0.000175	CcSEcCtD
Gadoteridol—Abdominal pain—Methotrexate—hematologic cancer	0.000174	0.000174	CcSEcCtD
Gadoteridol—Body temperature increased—Methotrexate—hematologic cancer	0.000174	0.000174	CcSEcCtD
Gadoteridol—Paraesthesia—Doxorubicin—hematologic cancer	0.000171	0.000171	CcSEcCtD
Gadoteridol—Dyspnoea—Doxorubicin—hematologic cancer	0.00017	0.00017	CcSEcCtD
Gadoteridol—Feeling abnormal—Epirubicin—hematologic cancer	0.00017	0.00017	CcSEcCtD
Gadoteridol—Vomiting—Prednisone—hematologic cancer	0.000168	0.000168	CcSEcCtD
Gadoteridol—Rash—Prednisone—hematologic cancer	0.000166	0.000166	CcSEcCtD
Gadoteridol—Dermatitis—Prednisone—hematologic cancer	0.000166	0.000166	CcSEcCtD
Gadoteridol—Headache—Prednisone—hematologic cancer	0.000165	0.000165	CcSEcCtD
Gadoteridol—Urticaria—Epirubicin—hematologic cancer	0.000164	0.000164	CcSEcCtD
Gadoteridol—Pain—Doxorubicin—hematologic cancer	0.000163	0.000163	CcSEcCtD
Gadoteridol—Body temperature increased—Epirubicin—hematologic cancer	0.000163	0.000163	CcSEcCtD
Gadoteridol—Abdominal pain—Epirubicin—hematologic cancer	0.000163	0.000163	CcSEcCtD
Gadoteridol—Hypersensitivity—Methotrexate—hematologic cancer	0.000162	0.000162	CcSEcCtD
Gadoteridol—Feeling abnormal—Doxorubicin—hematologic cancer	0.000157	0.000157	CcSEcCtD
Gadoteridol—Nausea—Prednisone—hematologic cancer	0.000157	0.000157	CcSEcCtD
Gadoteridol—Pruritus—Methotrexate—hematologic cancer	0.000156	0.000156	CcSEcCtD
Gadoteridol—Hypersensitivity—Epirubicin—hematologic cancer	0.000152	0.000152	CcSEcCtD
Gadoteridol—Urticaria—Doxorubicin—hematologic cancer	0.000152	0.000152	CcSEcCtD
Gadoteridol—Abdominal pain—Doxorubicin—hematologic cancer	0.000151	0.000151	CcSEcCtD
Gadoteridol—Body temperature increased—Doxorubicin—hematologic cancer	0.000151	0.000151	CcSEcCtD
Gadoteridol—Diarrhoea—Methotrexate—hematologic cancer	0.000151	0.000151	CcSEcCtD
Gadoteridol—Pruritus—Epirubicin—hematologic cancer	0.000146	0.000146	CcSEcCtD
Gadoteridol—Dizziness—Methotrexate—hematologic cancer	0.000146	0.000146	CcSEcCtD
Gadoteridol—Diarrhoea—Epirubicin—hematologic cancer	0.000141	0.000141	CcSEcCtD
Gadoteridol—Hypersensitivity—Doxorubicin—hematologic cancer	0.000141	0.000141	CcSEcCtD
Gadoteridol—Vomiting—Methotrexate—hematologic cancer	0.00014	0.00014	CcSEcCtD
Gadoteridol—Rash—Methotrexate—hematologic cancer	0.000139	0.000139	CcSEcCtD
Gadoteridol—Dermatitis—Methotrexate—hematologic cancer	0.000139	0.000139	CcSEcCtD
Gadoteridol—Headache—Methotrexate—hematologic cancer	0.000138	0.000138	CcSEcCtD
Gadoteridol—Dizziness—Epirubicin—hematologic cancer	0.000136	0.000136	CcSEcCtD
Gadoteridol—Pruritus—Doxorubicin—hematologic cancer	0.000135	0.000135	CcSEcCtD
Gadoteridol—Vomiting—Epirubicin—hematologic cancer	0.000131	0.000131	CcSEcCtD
Gadoteridol—Nausea—Methotrexate—hematologic cancer	0.000131	0.000131	CcSEcCtD
Gadoteridol—Diarrhoea—Doxorubicin—hematologic cancer	0.000131	0.000131	CcSEcCtD
Gadoteridol—Rash—Epirubicin—hematologic cancer	0.00013	0.00013	CcSEcCtD
Gadoteridol—Dermatitis—Epirubicin—hematologic cancer	0.00013	0.00013	CcSEcCtD
Gadoteridol—Headache—Epirubicin—hematologic cancer	0.000129	0.000129	CcSEcCtD
Gadoteridol—Dizziness—Doxorubicin—hematologic cancer	0.000126	0.000126	CcSEcCtD
Gadoteridol—Nausea—Epirubicin—hematologic cancer	0.000123	0.000123	CcSEcCtD
Gadoteridol—Vomiting—Doxorubicin—hematologic cancer	0.000121	0.000121	CcSEcCtD
Gadoteridol—Rash—Doxorubicin—hematologic cancer	0.00012	0.00012	CcSEcCtD
Gadoteridol—Dermatitis—Doxorubicin—hematologic cancer	0.00012	0.00012	CcSEcCtD
Gadoteridol—Headache—Doxorubicin—hematologic cancer	0.00012	0.00012	CcSEcCtD
Gadoteridol—Nausea—Doxorubicin—hematologic cancer	0.000113	0.000113	CcSEcCtD
